black box warning for semaglutide US FDA removes suicidal thoughts from weight-loss drugs FDA Says to Drop Suicide

Because subtherapeutic dosing sits below the FDA-approved starting dose and lacks randomized trial support, providers will explain the trade-offs honestly: the appeal (slower onset, reduced GI side-effect reports, lower cost) and the limits (no efficacy guarantee, no proven cardiovascular benefit at microdose levels, ongoing safety monitoring still required)

Understanding these variables helps set realistic expectations and prevents unnecessary frustration

The most frequently reported side effects were mild to moderate gastrointestinal events such as nausea, vomiting, constipation, diarrhoea or bloating, as expected

How Often Do You Have To Take Semaglutide